Ligand Pharmaceuticals, Inc. <LGND.O>: H.C. Wainwright raises target price to $358 from $289
LGND•Related News
Unity jumps after upbeat Q2 revenue
U•
JPMorgan Chase trades Exail Technologies shares around EUR 124.9 during offer period
JPM•
Where Food Comes From FY26 Q2 net income falls to $413,000; revenue rises to $6.61 million
WFCF•
Nasdaq trade halt continues <SUGP.O> volatility trading pause at 12:33 PM
SUGP•
North Sea Crude - Johan Sverdrup trades lower
EQNR•